Earnings Outlook For Biora Therapeutics
Portfolio Pulse from Benzinga Insights
Biora Therapeutics (NASDAQ:BIOR) is scheduled to release its quarterly earnings report on March 26, 2024, with analysts expecting an EPS of $-0.59. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates by $0.01 but resulting in a 2.19% share price drop. Over the last year, BIOR shares have declined by 53.88%, indicating a bearish outlook among long-term investors.
March 25, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biora Therapeutics is expected to report an EPS of $-0.59 for the upcoming quarter. Historical performance shows a mixed impact on stock prices post-earnings, with a notable decline of 53.88% over the past year.
Given the expected EPS and historical performance, BIOR's stock might face downward pressure post-earnings. The consistent decline over the past year further supports a bearish outlook, suggesting that unless the earnings significantly exceed expectations, the trend may continue.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100